The purpose of this study is to evaluate the safety and efficacy of fluconazole for the treatment of tinea capitis in pediatric patients aged 3 to 12 years.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
185
Fluconazole oral suspension 6 mg/kg/day for 6 weeks followed by 4 weeks without treatment
Combined clinical and mycological outcome at Week 6
Time frame: Week 6
Clinical outcome based on signs and symptoms at Weeks 3, 6, and 10
Time frame: Weeks 3, 6, and 10
Combined clinical and mycological outcome at Weeks 3 and 10
Time frame: Weeks 3 and 10
Mycological outcome based on culture results at Weeks 3, 6, and 10
Time frame: Weeks 3, 6, and 10
Culture results at Weeks 3, 6, and 10
Time frame: Weeks 3, 6, and 10
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Pfizer Investigational Site
Montgomery, Alabama, United States
Pfizer Investigational Site
Little Rock, Arkansas, United States
Pfizer Investigational Site
San Diego, California, United States
Pfizer Investigational Site
Miami, Florida, United States
Pfizer Investigational Site
Miami, Florida, United States
Pfizer Investigational Site
Martinez, Georgia, United States
Pfizer Investigational Site
Chicago, Illinois, United States
Pfizer Investigational Site
Evanston, Illinois, United States
Pfizer Investigational Site
Gretna, Louisiana, United States
Pfizer Investigational Site
New Orleans, Louisiana, United States
...and 21 more locations